Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours

  • Sara Costa-Cabral,
  • Rachel Brough,
  • Asha Konde,
  • Marieke Aarts,
  • James Campbell,
  • Eliana Marinari,
  • Jenna Riffell,
  • Alberto Bardelli,
  • Christopher Torrance,
  • Christopher J. Lord,
  • Alan Ashworth
  • Article
  • Metrics
  • Comments
  • Media Coverage

There is an error in the Correction published on April 20, 2017. The correct affiliation for the eighth author, Alberto Bartelli, is Candiolo Cancer Institute-FPO, IRCCS, Candiolo, TO, Italy and Department of Oncology, University of Torino, Candiolo, TO 10060, Italy.

References

  1. 1. Costa-Cabral S, Brough R, Konde A, Aarts M, Campbell J, Marinari E, et al. (2016) CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours. PLoS ONE 11(2): e0149099. https://doi.org/10.1371/journal.pone.0149099 pmid:26881434
  2. 2. Costa-Cabral S, Brough R, Konde A, Aarts M, Campbell J, Marinari E, et al. (2017) Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours. PLoS ONE 12(4): e0176578. https://doi.org/10.1371/journal.pone.0176578 pmid:28426773

Citation: Costa-Cabral S, Brough R, Konde A, Aarts M, Campbell J, Marinari E, et al. (2018) Correction: Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours. PLoS ONE 13(10): e0206729. https://doi.org/10.1371/journal.pone.0206729

Published: October 26, 2018

Copyright: © 2018 Costa-Cabral et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.